Sequent Good Will vs Accounts Payable Analysis

SEQUENT Stock

199.27 1.09 0.55%

Sequent Scientific financial indicator trend analysis is much more than just breaking down Sequent Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sequent Scientific is a good investment. Please check the relationship between Sequent Scientific Good Will and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sequent Scientific Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Good Will vs Accounts Payable

Good Will vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sequent Scientific Good Will account and Accounts Payable. At this time, the significance of the direction appears to have strong relationship.

The correlation between Sequent Scientific's Good Will and Accounts Payable is 0.72. Overlapping area represents the amount of variation of Good Will that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Sequent Scientific Limited, assuming nothing else is changed. The correlation between historical values of Sequent Scientific's Good Will and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Good Will of Sequent Scientific Limited are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Good Will i.e., Sequent Scientific's Good Will and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.72

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Good Will

An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.

Accounts Payable

An accounting item on the balance sheet that represents Sequent Scientific obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Sequent Scientific are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Sequent Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sequent Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sequent Scientific Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Discontinued Operations is likely to gain to about 5.1 B in 2024, whereas Selling General Administrative is likely to drop slightly above 297 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	135.1M	355.2M	480.9M	281.8M
Depreciation And Amortization	510.9M	556.9M	615.4M	375.0M

Interest Expense Depreciation And Amortization

Sequent Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Good Will	Accounts Payable	Short Term Investments	Intangible Assets	Current Deferred Revenue
Total Assets		0.66	0.25	0.83	0.93	0.68	0.57	0.72	0.95	0.62	0.85	0.89	0.96	0.8	0.66	0.48	0.84	0.87	0.93	0.96	0.57	0.91	0.81	0.53	0.69	0.57
Short Long Term Debt Total	0.66		-0.12	0.81	0.39	0.69	0.99	0.38	0.61	0.26	0.37	0.54	0.62	0.83	0.51	0.46	0.37	0.87	0.63	0.65	0.79	0.48	0.52	0.16	0.18	0.19
Other Current Liab	0.25	-0.12		0.3	0.22	0.24	-0.15	0.17	0.36	0.5	0.4	0.02	0.09	0.12	-0.13	0.4	0.2	0.26	0.09	0.06	0.15	0.04	0.03	0.4	0.4	0.63
Total Current Liabilities	0.83	0.81	0.3		0.61	0.59	0.74	0.67	0.73	0.57	0.59	0.75	0.8	0.73	0.64	0.55	0.57	0.97	0.84	0.79	0.88	0.57	0.78	0.21	0.59	0.5
Total Stockholder Equity	0.93	0.39	0.22	0.61		0.53	0.3	0.66	0.89	0.6	0.89	0.84	0.9	0.6	0.59	0.39	0.9	0.65	0.86	0.9	0.3	0.95	0.75	0.64	0.73	0.57
Property Plant And Equipment Net	0.68	0.69	0.24	0.59	0.53		0.69	0.25	0.74	0.11	0.54	0.46	0.58	0.81	0.35	0.45	0.47	0.7	0.53	0.6	0.4	0.55	0.39	0.53	0.08	0.34
Net Debt	0.57	0.99	-0.15	0.74	0.3	0.69		0.23	0.55	0.21	0.27	0.43	0.52	0.8	0.43	0.49	0.27	0.8	0.52	0.55	0.75	0.39	0.41	0.16	0.1	0.15
Cash	0.72	0.38	0.17	0.67	0.66	0.25	0.23		0.56	0.39	0.71	0.85	0.8	0.46	0.67	-0.03	0.67	0.65	0.82	0.78	0.51	0.66	0.81	0.07	0.53	0.28
Non Current Assets Total	0.95	0.61	0.36	0.73	0.89	0.74	0.55	0.56		0.68	0.87	0.72	0.86	0.84	0.44	0.59	0.82	0.81	0.77	0.86	0.47	0.86	0.6	0.71	0.62	0.64
Non Currrent Assets Other	0.62	0.26	0.5	0.57	0.6	0.11	0.21	0.39	0.68		0.56	0.41	0.52	0.41	0.18	0.63	0.54	0.55	0.48	0.49	0.39	0.48	0.36	0.43	0.82	0.74
Cash And Short Term Investments	0.85	0.37	0.4	0.59	0.89	0.54	0.27	0.71	0.87	0.56		0.7	0.78	0.62	0.4	0.37	0.88	0.63	0.73	0.78	0.33	0.83	0.6	0.76	0.61	0.6
Net Receivables	0.89	0.54	0.02	0.75	0.84	0.46	0.43	0.85	0.72	0.41	0.7		0.96	0.62	0.83	0.16	0.75	0.76	0.98	0.94	0.51	0.85	0.92	0.2	0.63	0.35
Common Stock Shares Outstanding	0.96	0.62	0.09	0.8	0.9	0.58	0.52	0.8	0.86	0.52	0.78	0.96		0.75	0.75	0.3	0.83	0.83	0.96	0.99	0.56	0.9	0.87	0.35	0.63	0.41
Non Current Liabilities Total	0.8	0.83	0.12	0.73	0.6	0.81	0.8	0.46	0.84	0.41	0.62	0.62	0.75		0.46	0.44	0.51	0.86	0.66	0.75	0.61	0.69	0.5	0.44	0.33	0.32
Inventory	0.66	0.51	-0.13	0.64	0.59	0.35	0.43	0.67	0.44	0.18	0.4	0.83	0.75	0.46		0.05	0.48	0.62	0.83	0.74	0.56	0.63	0.89	-0.09	0.51	0.02
Other Current Assets	0.48	0.46	0.4	0.55	0.39	0.45	0.49	-0.03	0.59	0.63	0.37	0.16	0.3	0.44	0.05		0.35	0.55	0.3	0.3	0.4	0.27	0.26	0.55	0.51	0.66
Other Stockholder Equity	0.84	0.37	0.2	0.57	0.9	0.47	0.27	0.67	0.82	0.54	0.88	0.75	0.83	0.51	0.48	0.35		0.58	0.76	0.85	0.25	0.84	0.65	0.61	0.56	0.52
Total Liab	0.87	0.87	0.26	0.97	0.65	0.7	0.8	0.65	0.81	0.55	0.63	0.76	0.83	0.86	0.62	0.55	0.58		0.83	0.83	0.85	0.64	0.74	0.3	0.54	0.47
Total Current Assets	0.93	0.63	0.09	0.84	0.86	0.53	0.52	0.82	0.77	0.48	0.73	0.98	0.96	0.66	0.83	0.3	0.76	0.83		0.95	0.61	0.85	0.94	0.28	0.69	0.42
Common Stock	0.96	0.65	0.06	0.79	0.9	0.6	0.55	0.78	0.86	0.49	0.78	0.94	0.99	0.75	0.74	0.3	0.85	0.83	0.95		0.57	0.92	0.86	0.38	0.6	0.36
Short Term Debt	0.57	0.79	0.15	0.88	0.3	0.4	0.75	0.51	0.47	0.39	0.33	0.51	0.56	0.61	0.56	0.4	0.25	0.85	0.61	0.57		0.32	0.61	-0.01	0.4	0.15
Good Will	0.91	0.48	0.04	0.57	0.95	0.55	0.39	0.66	0.86	0.48	0.83	0.85	0.9	0.69	0.63	0.27	0.84	0.64	0.85	0.92	0.32		0.72	0.56	0.63	0.36
Accounts Payable	0.81	0.52	0.03	0.78	0.75	0.39	0.41	0.81	0.6	0.36	0.6	0.92	0.87	0.5	0.89	0.26	0.65	0.74	0.94	0.86	0.61	0.72		0.09	0.66	0.27
Short Term Investments	0.53	0.16	0.4	0.21	0.64	0.53	0.16	0.07	0.71	0.43	0.76	0.2	0.35	0.44	-0.09	0.55	0.61	0.3	0.28	0.38	-0.01	0.56	0.09		0.37	0.61
Intangible Assets	0.69	0.18	0.4	0.59	0.73	0.08	0.1	0.53	0.62	0.82	0.61	0.63	0.63	0.33	0.51	0.51	0.56	0.54	0.69	0.6	0.4	0.63	0.66	0.37		0.59
Current Deferred Revenue	0.57	0.19	0.63	0.5	0.57	0.34	0.15	0.28	0.64	0.74	0.6	0.35	0.41	0.32	0.02	0.66	0.52	0.47	0.42	0.36	0.15	0.36	0.27	0.61	0.59

Click cells to compare fundamentals

Sequent Scientific Account Relationship Matchups

Sequent Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	15.2B	13.9B	14.4B	15.3B	15.4B	10.6B
Short Long Term Debt Total	3.9B	2.8B	3.6B	4.4B	4.9B	3.1B
Other Current Liab	474.9M	734.6M	418.9M	134.1M	393.8M	610.9M
Total Current Liabilities	4.7B	4.6B	5.1B	5.3B	6.3B	3.8B
Total Stockholder Equity	7.4B	7.3B	6.9B	7.0B	6.6B	4.5B
Property Plant And Equipment Net	3.6B	3.5B	3.3B	3.5B	3.1B	2.9B
Net Debt	3.2B	2.2B	3.1B	4.0B	4.2B	2.8B
Cash	681.0M	537.4M	575.0M	415.7M	648.1M	354.1M
Non Current Assets Total	8.1B	6.8B	6.5B	7.4B	7.2B	5.9B
Non Currrent Assets Other	140.1M	150.8M	222.1M	332.8M	312.9M	269.9M
Cash And Short Term Investments	1.1B	597.0M	591.2M	428.8M	687.9M	477.7M
Net Receivables	3.2B	3.5B	3.3B	3.4B	3.4B	2.0B
Common Stock Shares Outstanding	245.3M	247.9M	250.7M	250.1M	249.1M	185.4M
Liabilities And Stockholders Equity	15.2B	13.9B	14.4B	15.3B	15.4B	10.6B
Non Current Liabilities Total	2.6B	1.6B	1.9B	2.5B	2.0B	2.0B
Inventory	2.2B	2.6B	3.5B	3.5B	3.5B	3.6B
Other Current Assets	576.8M	436.9M	470.3M	612.2M	735.7M	616.3M
Other Stockholder Equity	8.4B	8.6B	8.7B	2.0B	8.7B	4.9B
Total Liab	7.3B	6.2B	7.0B	7.8B	8.3B	5.7B
Total Current Assets	7.0B	7.1B	7.9B	7.9B	8.2B	4.7B
Accumulated Other Comprehensive Income	(1.4B)	(2.5B)	(3.1B)	(3.5B)	(3.9B)	(3.7B)
Short Term Debt	2.0B	1.4B	2.0B	2.6B	3.2B	2.0B
Good Will	2.4B	1.7B	1.9B	2.4B	2.3B	1.5B
Accounts Payable	2.2B	2.3B	2.6B	2.4B	2.6B	1.9B
Short Term Investments	401.8M	59.6M	16.3M	13.1M	39.8M	37.8M
Intangible Assets	517.0M	443.9M	559.5M	684.2M	617.2M	535.8M
Current Deferred Revenue	510.2M	812.5M	397.2M	338.4M	81.3M	77.2M
Retained Earnings	(791.2M)	599.7M	888.9M	996.9M	1.2B	1.3B
Other Liab	543.4M	326.2M	162.4M	246.5M	221.9M	378.6M
Net Tangible Assets	4.5B	5.1B	4.5B	3.9B	4.5B	4.5B
Other Assets	372.3M	355.9M	514.1M	502.9M	(1.0)	(0.95)
Long Term Debt	1.5B	937.1M	1.2B	1.8B	1.4B	1.3B
Short Long Term Debt	1.8B	1.0B	1.9B	2.2B	3.1B	2.1B
Property Plant Equipment	3.6B	3.5B	3.3B	3.5B	3.2B	2.7B
Long Term Debt Total	2.0B	1.4B	1.2B	2.2B	2.0B	1.3B
Capital Surpluse	8.6B	8.7B	8.7B	9.0B	8.1B	7.2B
Capital Lease Obligations	607.2M	522.9M	500.1M	457.0M	364.1M	354.1M
Non Current Liabilities Other	13.1M	8.7M	6.8M	3.7M	3.3M	3.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Sequent Stock Analysis

When running Sequent Scientific's price analysis, check to measure Sequent Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequent Scientific is operating at the current time. Most of Sequent Scientific's value examination focuses on studying past and present price action to predict the probability of Sequent Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequent Scientific's price. Additionally, you may evaluate how the addition of Sequent Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sequent Good Will vs Accounts Payable Analysis

Good Will vs Accounts Payable

Good Will vs Accounts Payable Correlation Analysis

Correlation Coefficient

Good Will

Accounts Payable

Sequent Scientific fundamental ratios Correlations

Sequent Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sequent Scientific fundamental ratios Accounts

Also Currently Popular

Additional Tools for Sequent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 0.99	Short Long Term Debt Total
Common Stock	+ 0.99	Common Stock Shares Outstanding
Total Current Assets	+ 0.98	Net Receivables
Total Liab	+ 0.97	Total Current Liabilities
Common Stock Shares Outstanding	+ 0.96	Total Assets
Common Stock	+ 0.96	Total Assets

Net Debt	- 0.15	Other Current Liab
Inventory	- 0.13	Other Current Liab
Other Current Liab	- 0.12	Short Long Term Debt Total
Short Term Investments	- 0.09	Inventory
Other Current Assets	- 0.03	Cash
Short Term Investments	- 0.01	Short Term Debt